New Equilibrium Biosciences

AI-based computational-experimental platform for drug discovery

placeBoston, Massachusetts, United States calendar_todayFounded 2018 groups10 employees language newequilibriumbio.com

Registered entities

Investor mix

4 investors on record; lead investors include Petri, RA Capital Management.

Investor typeCountShare
Venture capital125%
Accelerator & incubator125%
Other / undisclosed250%
Coming soon